Total Payments
$3,142
2024 Payments
$913.52
Companies
30
Transactions
201
Medicare Patients
8,733
Medicare Billing
$927,624
Payment Breakdown by Category
Food & Beverage$3,078 (97.9%)
Education$64.54 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,078 | 199 | 97.9% |
| Education | $64.54 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $571.66 | 31 | $0 (2024) |
| ABBVIE INC. | $488.99 | 39 | $0 (2024) |
| Amgen Inc. | $333.25 | 19 | $0 (2024) |
| PFIZER INC. | $230.66 | 14 | $0 (2024) |
| Amarin Pharma Inc. | $226.58 | 16 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $165.14 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $157.31 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $104.77 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $75.58 | 5 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $75.11 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $913.52 | 50 | Novo Nordisk Inc ($297.38) |
| 2023 | $731.49 | 49 | Novo Nordisk Inc ($181.07) |
| 2022 | $771.90 | 53 | Amgen Inc. ($167.31) |
| 2021 | $519.68 | 34 | Amarin Pharma Inc. ($114.58) |
| 2020 | $205.81 | 15 | Amarin Pharma Inc. ($112.00) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.71 | General |
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes Care | ||||||
| 10/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: Obesity | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Gastroenterology | ||||||
| 09/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Obesity | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: VACCINE | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.96 | General |
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardio-renal | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,204 | 3,496 | $534,391 | $264,301 |
| 2022 | 22 | 2,406 | 3,902 | $600,112 | $287,900 |
| 2021 | 25 | 2,764 | 3,883 | $556,102 | $276,087 |
| 2020 | 14 | 1,359 | 1,434 | $201,338 | $99,335 |
Total Patients
8,733
Total Services
12,715
Medicare Billing
$927,624
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 26 | 26 | $10,114 | $6,462 | 63.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 22 | 25 | $13,575 | $5,308 | 39.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 150 | 153 | $10,557 | $4,214 | 39.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 30 | 30 | $6,300 | $3,967 | 63.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $14,544 | $3,679 | 25.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 83 | 87 | $6,873 | $2,994 | 43.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 91 | 92 | $3,496 | $2,548 | 72.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 15 | $5,760 | $2,209 | 38.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 106 | 135 | $8,910 | $1,257 | 14.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 29 | 59 | $2,478 | $939.37 | 37.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 46 | 50 | $4,650 | $509.74 | 11.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 13 | 14 | $1,568 | $378.62 | 24.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 39 | $1,599 | $349.85 | 21.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 65 | 80 | $2,480 | $177.83 | 7.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 25 | 92 | $460.00 | $6.36 | 1.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 777 | 1,542 | $254,430 | $133,082 | 52.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 408 | 653 | $75,748 | $36,805 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 144 | 144 | $25,200 | $18,177 | 72.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 264 | 268 | $20,100 | $17,464 | 86.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 123 | 142 | $31,950 | $15,871 | 49.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 89 | 89 | $27,590 | $14,287 | 51.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 120 | 120 | $36,360 | $12,294 | 33.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 43 | 43 | $9,030 | $5,355 | 59.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 21 | 21 | $8,169 | $5,035 | 61.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 281 | 285 | $19,665 | $4,542 | 23.1% |
About Dr. Michael Sperling, M.D
Dr. Michael Sperling, M.D is a Internal Medicine healthcare provider based in Little River, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2017. The National Provider Identifier (NPI) number assigned to this provider is 1326579392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sperling, M.D has received a total of $3,142 in payments from pharmaceutical and medical device companies, with $913.52 received in 2024. These payments were reported across 201 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,078).
As a Medicare-enrolled provider, Sperling has provided services to 8,733 Medicare beneficiaries, totaling 12,715 services with total Medicare billing of $927,624. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Little River, SC
- Active Since 03/22/2017
- Last Updated 02/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326579392
Products in Payments
- Ozempic (Drug) $247.99
- Vascepa (Drug) $226.58
- Otezla (Drug) $207.00
- QULIPTA (Drug) $202.29
- ELIQUIS (Drug) $199.29
- Wegovy (Drug) $196.31
- VRAYLAR (Drug) $156.32
- XIFAXAN (Drug) $104.77
- UBRELVY (Drug) $94.96
- Rybelsus (Drug) $88.08
- FARXIGA (Drug) $82.24
- Kerendia (Drug) $75.58
- XARELTO (Drug) $73.89
- EVENITY (Biological) $67.52
- Dexcom G6 Transmitter (Medical Supply) $58.26
- GEMTESA (Drug) $54.90
- GVOKE PFS (Drug) $54.03
- ENTRESTO (Drug) $53.96
- AREXVY (Drug) $50.00
- SHINGRIX (Biological) $48.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Little River
Dr. Yuxuan Mao, M.d., M.s, M.D., M.S
Internal Medicine — Payments: $87,660
Internal Medicine $87,660
Marc Comianos, Do, DO
Internal Medicine — Payments: $17,613
Internal Medicine $17,613
Kevin Dineen, Md, MD
Internal Medicine — Payments: $14,769
Internal Medicine $14,769
Dr. Donny Huynh, M.d, M.D
Internal Medicine — Payments: $8,317
Internal Medicine $8,317
Dr. Ruth Wieland, Md, MD
Internal Medicine — Payments: $7,362
Internal Medicine $7,362
Dr. Robert Prinzi, Md, MD
Internal Medicine — Payments: $3,545
Internal Medicine $3,545